VANDA PHARMACEUTICALS INC. (VNDA) Operating margin 2016–2025
VANDA PHARMACEUTICALS INC. (VNDA) operating margin by fiscal year — reported operating income divided by reported revenue.
-70.0%FY2025 · since FY2016: -12.7% → -70.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -70.0% | -49.5 pp |
| FY2024 | -20.5% | -13.2 pp |
| FY2023 | -7.2% | -9.7 pp |
| FY2022 | 2.5% | -13.2 pp |
| FY2021 | 15.7% | +4.7 pp |
| FY2020 | 11.0% | +0.9 pp |
| FY2019 | 10.0% | -1.2 pp |
| FY2018 | 11.3% | +21.5 pp |
| FY2017 | -10.2% | +2.5 pp |
| FY2016 | -12.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More VNDA financial trends
VNDA RevenueVNDA Net incomeVNDA Net marginVNDA Gross profitVNDA Gross marginVNDA Operating incomeVNDA Operating cash flowVNDA Free cash flowVNDA Capital expendituresVNDA Return on equityVNDA Stock buybacksVNDA Dividends paidVNDA Total assetsVNDA Total liabilitiesVNDA Shareholders’ equityVNDA overview →